Membrane lipid replacement

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history

Membrane Lipid Replacement or MLR.

Notable studies[edit | edit source]

  • 2017, Membrane Lipid Replacement for chronic illnesses, aging and cancer using oral glycerolphospholipid formulations with fructooligosaccharides to restore phospholipid function in cellular membranes, organelles, cells and tissues[1] (Full text)

Learn more[edit | edit source]

See also[edit | edit source]

References[edit | edit source]

  1. ↑ Nicolson, Garth E.; Ash, Michael E. (September 1, 2017). "Membrane Lipid Replacement for chronic illnesses, aging and cancer using oral glycerolphospholipid formulations with fructooligosaccharides to restore phospholipid function in cellular membranes, organelles, cells and tissues". Biochimica et Biophysica Acta (BBA) - Biomembranes. 1859 (9): 1704–1724. doi:10.1016/j.bbamem.2017.04.013. ISSN 0005-2736.
Retrieved from "https://me-pedia.org/w/index.php?title=Membrane_lipid_replacement&oldid=227908"